JUL-AUG 2017

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link:

Contents of this Issue


Page 11 of 68 | JULY/AUGUST 2017 9 TOP: IMAGE COURTESY OF ELSEVIER HEALTH; BOTTOM: © GETTY IMAGES A Comprehensive Review of Soft Tissue Fillers Topical Minocycline Gel Achieves Acne Treatment Endpoints BioPharmX BPX-01, a solubilized topical mino - cycline gel developed for the treatment of mod- erate-to-severe acne, has achieved the primary endpoint in its randomized, double-blind, three- arm phase 2b clinical trial. Both the 1% and 2% doses showed statisti- cally signifi cant reductions in non-nodular infl am- matory acne lesions when compared to vehicle. The absolute mean change in the number of acne lesions from baseline to week 12 for each arm was: 15.5 (BPX-01 1%), 15.4 (BPX-01 2%) and 11.3 (vehicle). The secondary endpoint was defi ned as the proportion of subjects with at least a two-grade reduction in Investigator's Global Assessment (IGA) to clear "0" or almost clear "1." The pro- portion that achieved this endpoint was 22.7% for BPX-01 2%, 16% for BPX-01 1%, and 17.1% for vehicle. "These results represent a major milestone for the company and offer the potential of BPX-01 as the fi rst topical minocycline gel for moderate-to-severe acne, optimizing safety and effi cacy of a proven antibiotic for this con- dition to millions of patients," said Anja Kram- mer, co-founder and president of BioPharmX. "We look forward to sharing detailed phase 2b data with the investor and medical communi- ties over the coming months." For aesthetic providers who want to stay up to date on latest soft tissue fi ller products and injection techniques, Elsevier Health has released Soft Tissue Augmentation 4 th edi- tion. The updated textbook, edited by Jean Carruthers, MD, and Alastair Carruthers, MD, is organized into separate sections based on different types of fi llers, including permanent and non-permanent off-the-shelf fi llers, fat transplantation and platelet-rich plasma, and features a chapter on managing complications. Readers will learn about evidence-based practices and can improve their technique with procedural how-tos and step-by-step advice on proper fi ller technique. New additions include information on the Emervel family of fi llers, temple refl ation, neck and chest treatments, vascular compromise and the tower technique of fi ller injection. Purchases include the Expert Consult eBook, which allows you to search all of the text, fi gures and references from the book on a variety of electronic devices. For more information, visit Patient retention is a critical concern for aesthetics practices. With so much com- petition in the marketplace, you want to do everything you can to hold onto your most valued patrons. One way to do this is to create a VIP experience. Catherine Maley, founder of Cosmetic Image Marketing, encourages practices to take a cue from the airlines by offering a variety of special perks and upgrades to their most valued patients. These may be individuals who spend a certain amount of money in your business each year or those who regularly refer their friends and families. Some perks to consider include: • 15% off skincare products • A free monthly chemical peel • Free parking • No-waiting Botox appointmentss CREATING THE VIP EXPERIENCE

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - JUL-AUG 2017